Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT01199133
Eligibility Criteria:
Inclusion Criteria:
* Male or female outpatients, aged 5-17 years inclusive
* History of house dust mite-related allergic rhinitis for at least 1 year requiring regular intake of symptomatic treatment(s)
* Sensitised to D. pteronyssinus and/or D. farinae (positive skin prick test with wheal diameter greater than 3 mm and specific IgE level ≥ 0.7 kU/L)
Exclusion Criteria:
• Co-sensitization associated with clinically relevant allergic rhinitis, sinusitis, conjunctivitis or asthma likely to significantly change the symptoms of the patient throughout the study (that means patient symptomatic to another allergen than house dust mites to which the patient will be exposed during the study, i.e. will notably be excluded
* patients sensitised to cat or dog allergens and regularly exposed to these allergens
* patients sensitised to aspergillus, cladosporium, alternaria
* patients sensitised to parietaria , ragweed, or mugwort, if this allergen is endemic to the region
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
17 Years
Study:
NCT01199133
Study Brief:
Protocol Section:
NCT01199133